Donte DiVincenzo: Everything you need to know

Donte DiVincenzo

Minnesota Timberwolves

Status

OUT - Achilles - Surgery Expected Return: 2027-04-01

STATS

Career Averages

PTS

REB

AST

BLK

STL

11.0

4.3

3.0

0.3

1.2

Year	GP	GS	MIN	PTS	REB	AST	BLK	STL	TO	DD2	3PM	3PA	3P%	2PM	2PA	2P%	FGM	FGA	FG%	FTM	FTA	FT%	OREB	DREB	PF	A/TO	+/-	TS%
2025-26	82	82	30.4	12.2	4.1	3.8	0.4	1.3	1.4	1	3.0	7.9	37.9%	1.2	2.3	49.7%	4.1	10.2	40.6%	1.0	1.3	74.3%	0.8	3.3	2.4	2.7	+337	56.7%
2024-25	62	10	25.9	11.7	3.7	3.6	0.3	1.2	1.6	1	2.8	7.1	39.7%	1.2	2.5	49.0%	4.0	9.6	42.2%	0.8	1.0	77.8%	0.5	3.2	1.8	2.3	+174	58.2%
2023-24	81	63	29.1	15.5	3.7	2.7	0.4	1.3	1.4	0	3.5	8.7	40.1%	2.0	3.7	54.2%	5.5	12.4	44.3%	1.1	1.4	75.4%	0.8	2.9	2.0	1.9	+162	59.7%
2022-23	72	36	26.3	9.4	4.5	3.5	0.1	1.3	1.6	4	2.1	5.3	39.7%	1.2	2.3	52.5%	3.3	7.5	43.5%	0.8	1.0	81.7%	1.1	3.4	1.8	2.3	+124	59.3%
2021-22	42	1	24.0	9.0	4.0	2.8	0.2	1.1	1.7	0	1.8	5.2	33.9%	1.0	2.8	37.3%	2.8	8.0	35.1%	1.7	2.0	84.3%	1.0	3.1	1.6	1.6	-75	51.0%
2020-21	66	66	27.5	10.4	5.8	3.1	0.2	1.1	1.4	5	2.0	5.2	37.9%	1.8	3.9	47.5%	3.8	9.1	42.0%	0.8	1.1	71.8%	1.2	4.5	1.7	2.2	+304	54.2%
2019-20	66	24	23.0	9.2	4.8	2.3	0.3	1.3	1.4	1	1.3	3.7	33.6%	2.3	4.0	56.7%	3.5	7.7	45.5%	1.0	1.3	73.3%	1.0	3.8	1.7	1.7	+409	55.7%
2018-19	31	4	16.9	6.2	2.6	1.3	0.3	0.6	1.2	0	0.9	3.5	26.6%	1.4	2.1	65.2%	2.3	5.6	41.1%	0.6	0.8	79.2%	0.7	1.9	1.5	1.1	+92	51.7%
Career	502	286	26.3	11.0	4.3	3.0	0.3	1.2	1.5	12	2.3	6.1	37.9%	1.5	3.0	51.4%	3.9	9.2	42.3%	0.9	1.2	76.8%	0.9	3.4	1.9	2.1	+1527	56.8%

Career Averages

PTS

REB

AST

BLK

STL

9.5

3.5

2.7

0.4

1.1

Year	GP	GS	MIN	PTS	REB	AST	BLK	STL	TO	3PM	3PA	3P%	2PM	2PA	2P%	FGM	FGA	FG%	FTM	FTA	FT%	OREB	DREB	PF	A/TO	+/-	TS%
2025-26	4	4	24.0	10.8	3.8	4.0	0.0	1.8	1.0	2.8	5.8	47.8%	1.3	2.3	55.6%	4.0	8.0	50.0%	0.0	0.5	0.0%	0.0	3.8	2.5	4.0	+45	65.4%
2024-25	15	0	25.1	8.7	3.1	3.3	0.3	1.4	1.9	1.9	5.9	31.8%	1.2	2.5	47.4%	3.1	8.4	36.5%	0.7	0.9	76.9%	0.8	2.3	3.0	1.8	-62	49.3%
2023-24	13	13	35.8	17.8	4.0	2.6	0.9	1.2	1.2	3.5	8.2	42.5%	2.7	6.5	41.2%	6.2	14.7	41.9%	2.0	2.3	86.7%	1.0	3.0	2.2	2.1	-59	56.6%
2022-23	13	1	18.1	5.5	3.0	2.8	0.2	0.8	1.3	1.2	3.4	34.1%	0.7	1.5	45.0%	1.8	4.9	37.5%	0.6	0.9	66.7%	0.8	2.2	1.5	2.1	-38	51.2%
2020-21	3	3	23.3	2.7	6.3	2.7	0.3	1.0	2.0	0.7	4.0	16.7%	0.3	1.3	25.0%	1.0	5.3	18.8%	0.0	0.0	0.0%	0.7	5.7	1.3	1.3	+12	25.0%
2019-20	10	1	16.5	6.6	3.2	1.2	0.3	0.7	1.0	0.7	2.1	33.3%	1.6	3.0	53.3%	2.3	5.1	45.1%	1.3	2.0	65.0%	0.8	2.4	2.1	1.2	-12	55.2%
Career	58	22	24.3	9.5	3.5	2.7	0.4	1.1	1.4	1.9	5.1	36.7%	1.4	3.2	45.2%	3.3	8.3	40.0%	1.0	1.3	74.0%	0.8	2.7	2.2	1.9	-114	53.4%

Preseason
Date	Opp	Result	MIN	PTS	REB	AST	BLK	STL	TO	3PA	3PM	3P%	2PA	2PM	2P%	FGA	FGM	FG%	FTA	FTM	FT%	OREB	DREB	A/TO	+/-	PF	PER	TS%
10/16	CHI	L 126-120	18	9	3	0	0	0	2	5	1	20.0%	3	3	100.0%	8	4	50.0%	0	0	0.0%	1	2	0.0	-5	1	5	56.3%
10/9	NYK	L 100-95	23	3	5	3	2	1	2	3	1	33.3%	0	0	0.0%	3	1	33.3%	0	0	0.0%	0	5	1.5	+10	1	9	50.0%
10/7	IND	L 135-134	8	3	2	1	1	0	2	2	1	50.0%	1	0	0.0%	3	1	33.3%	0	0	0.0%	2	0	0.5	+1	0	3	50.0%
10/4	DEN	W 126-116	12	8	1	6	1	1	0	4	2	50.0%	1	1	100.0%	5	3	60.0%	0	0	0.0%	0	1	0.0	+12	2	13	80.0%
Preseason Totals			15.7	5.8	2.8	2.5	1.0	0.5	1.5	3.5	1.3	35.7%	1.3	1.0	80.0%	4.8	2.3	47.4%	0.0	0.0	0.0%	0.8	2.0	1.7	+18	1.0	8.5	60.5%

Regular Season
Date	Opp	Result	MIN	PTS	REB	AST	BLK	STL	TO	3PA	3PM	3P%	2PA	2PM	2P%	FGA	FGM	FG%	FTA	FTM	FT%	OREB	DREB	A/TO	+/-	PF	PER	TS%
4/10	HOU	W 136-132	29	18	4	2	2	1	1	8	3	37.5%	4	3	75.0%	12	6	50.0%	6	3	50.0%	0	4	2.0	+1	3	17	61.5%
4/8	ORL	L 132-120	21	12	0	2	0	0	1	7	4	57.1%	0	0	0.0%	7	4	57.1%	0	0	0.0%	0	0	2.0	-15	3	9	85.7%
4/7	IND	W 124-104	30	11	6	4	0	1	1	10	3	30.0%	2	1	50.0%	12	4	33.3%	0	0	0.0%	2	4	4.0	+15	2	11	45.8%
4/5	CHA	L 122-108	27	6	1	3	0	2	2	8	2	25.0%	1	0	0.0%	9	2	22.2%	0	0	0.0%	0	1	1.5	-11	3	0	33.3%
4/3	PHI	L 115-103	28	11	0	1	0	0	0	9	3	33.3%	2	0	0.0%	11	3	27.3%	3	2	66.7%	0	0	0.0	-18	2	2	44.6%
4/2	DET	L 113-108	29	5	1	1	1	0	1	7	1	14.3%	1	1	100.0%	8	2	25.0%	0	0	0.0%	0	1	1.0	-8	3	2	31.3%
3/30	DAL	W 124-94	29	15	3	2	1	1	2	9	5	55.6%	2	0	0.0%	11	5	45.5%	0	0	0.0%	0	3	1.0	+30	1	13	68.2%
3/28	DET	L 109-87	33	22	3	2	2	0	1	14	5	35.7%	4	2	50.0%	18	7	38.9%	4	3	75.0%	0	3	2.0	-8	0	20	55.7%
3/25	HOU	W 110-108	36	17	3	2	0	2	2	12	5	41.7%	3	1	33.3%	15	6	40.0%	0	0	0.0%	1	2	1.0	+3	3	10	56.7%
3/22	BOS	W 102-92	30	8	2	2	0	1	2	7	2	28.6%	2	1	50.0%	9	3	33.3%	0	0	0.0%	0	2	1.0	+5	1	4	44.4%
3/20	POR	L 108-104	35	13	4	2	2	1	4	12	3	25.0%	4	2	50.0%	16	5	31.3%	0	0	0.0%	0	4	0.5	-14	4	5	40.6%
3/18	UTA	W 147-111	25	9	3	7	0	1	1	6	3	50.0%	1	0	0.0%	7	3	42.9%	0	0	0.0%	0	3	7.0	+14	3	14	64.3%
3/17	PHX	W 116-104	27	0	1	3	1	1	1	6	0	0.0%	2	0	0.0%	8	0	0.0%	0	0	0.0%	0	1	3.0	+3	1	4	0.0%
3/15	OKC	L 116-103	29	16	9	1	0	0	1	7	4	57.1%	2	2	100.0%	9	6	66.7%	0	0	0.0%	0	9	1.0	-7	1	22	88.9%
3/13	GSW	W 127-117	27	7	6	1	0	1	0	6	1	16.7%	3	2	66.7%	9	3	33.3%	0	0	0.0%	2	4	0.0	+11	2	11	38.9%
3/11	LAC	L 153-128	24	6	4	2	0	1	3	2	1	50.0%	3	1	33.3%	5	2	40.0%	2	1	50.0%	1	3	0.7	-12	2	6	51.0%
3/10	LAL	L 120-106	31	8	5	2	0	1	1	6	2	33.3%	3	1	33.3%	9	3	33.3%	0	0	0.0%	1	4	2.0	-15	3	5	44.4%
3/7	ORL	L 119-92	28	0	2	4	0	1	1	6	0	0.0%	0	0	0.0%	6	0	0.0%	0	0	0.0%	0	2	4.0	-13	2	1	0.0%
3/5	TOR	W 115-107	26	16	5	2	0	2	1	6	4	66.7%	1	0	0.0%	7	4	57.1%	4	4	100.0%	0	5	2.0	+16	1	23	91.3%
3/3	MEM	W 117-110	30	7	4	6	0	1	1	5	1	20.0%	2	2	100.0%	7	3	42.9%	0	0	0.0%	0	4	6.0	+21	1	14	50.0%
3/1	DEN	W 117-108	35	17	3	5	0	2	0	10	5	50.0%	0	0	0.0%	10	5	50.0%	3	2	66.7%	0	3	0.0	+3	2	20	75.1%
2/26	LAC	W 94-88	31	18	3	4	0	2	1	9	4	44.4%	4	2	50.0%	13	6	46.2%	2	2	100.0%	2	1	4.0	+8	2	20	64.8%
2/24	POR	W 124-121	32	19	1	4	0	2	1	10	5	50.0%	3	2	66.7%	13	7	53.8%	0	0	0.0%	0	1	4.0	+4	3	17	73.1%
2/22	PHI	L 135-108	27	11	6	3	0	0	4	5	3	60.0%	1	1	100.0%	6	4	66.7%	0	0	0.0%	2	4	0.8	-10	0	15	91.7%
2/20	DAL	W 122-111	30	9	5	9	0	1	1	5	3	60.0%	0	0	0.0%	5	3	60.0%	0	0	0.0%	0	5	9.0	+19	4	18	90.0%
2/11	POR	W 133-109	29	3	4	5	0	3	1	5	1	20.0%	0	0	0.0%	5	1	20.0%	0	0	0.0%	0	4	5.0	+26	3	7	30.0%
2/9	ATL	W 138-116	25	10	4	6	0	2	2	8	2	25.0%	2	2	100.0%	10	4	40.0%	0	0	0.0%	0	4	3.0	+9	0	15	50.0%
2/8	LAC	L 115-96	23	1	4	2	0	1	2	3	0	0.0%	0	0	0.0%	3	0	0.0%	2	1	50.0%	0	4	1.0	-3	6	2	12.9%
2/6	NOP	L 119-115	25	6	3	2	0	1	2	7	2	28.6%	3	0	0.0%	10	2	20.0%	0	0	0.0%	0	3	1.0	-6	2	0	30.0%
2/4	TOR	W 128-126	31	15	6	5	0	0	1	9	5	55.6%	2	0	0.0%	11	5	45.5%	0	0	0.0%	2	4	5.0	+1	4	15	68.2%
2/2	MEM	L 137-128	33	21	3	4	0	2	1	7	5	71.4%	2	2	100.0%	9	7	77.8%	4	2	50.0%	2	1	4.0	-3	2	25	97.6%
1/31	MEM	W 131-114	17	11	1	5	0	1	2	5	3	60.0%	2	1	50.0%	7	4	57.1%	0	0	0.0%	1	0	2.5	+7	5	7	78.6%
1/29	OKC	W 123-111	31	11	5	5	1	2	1	9	3	33.3%	4	1	25.0%	13	4	30.8%	0	0	0.0%	2	3	5.0	+12	4	10	42.3%
1/28	DAL	W 118-105	27	8	5	1	0	5	1	5	2	40.0%	3	1	33.3%	8	3	37.5%	0	0	0.0%	0	5	1.0	+9	2	11	50.0%
1/26	GSW	W 108-83	31	15	4	8	3	1	4	9	5	55.6%	1	0	0.0%	10	5	50.0%	0	0	0.0%	2	2	2.0	+12	1	20	75.0%
1/25	GSW	L 111-85	32	22	7	0	0	1	5	15	6	40.0%	4	1	25.0%	19	7	36.8%	2	2	100.0%	2	5	0.0	-21	3	10	55.3%
1/22	CHI	L 120-115	35	11	3	4	1	2	1	8	3	37.5%	2	1	50.0%	10	4	40.0%	0	0	0.0%	0	3	4.0	+1	3	14	55.0%
1/20	UTA	L 127-122	33	15	5	8	0	2	2	9	3	33.3%	3	2	66.7%	12	5	41.7%	2	2	100.0%	1	4	4.0	-14	3	20	58.2%
1/17	SAS	L 126-123	36	11	5	3	1	2	3	10	3	30.0%	4	1	25.0%	14	4	28.6%	0	0	0.0%	1	4	1.0	+7	3	6	39.3%
1/16	HOU	L 110-105	39	8	8	4	1	1	2	7	2	28.6%	3	1	33.3%	10	3	30.0%	0	0	0.0%	2	6	2.0	+5	4	10	40.0%
1/13	MIL	W 139-106	30	11	4	7	0	0	2	5	3	60.0%	1	1	100.0%	6	4	66.7%	0	0	0.0%	0	4	3.5	+23	0	18	91.7%
1/11	SAS	W 104-103	38	19	9	7	1	3	2	12	5	41.7%	4	2	50.0%	16	7	43.8%	0	0	0.0%	1	8	3.5	+3	3	27	59.4%
1/10	CLE	L 146-134	34	15	3	6	0	2	4	6	3	50.0%	3	3	100.0%	9	6	66.7%	0	0	0.0%	2	1	1.5	-11	0	20	83.3%
1/8	CLE	W 131-122	34	22	1	4	0	1	1	10	6	60.0%	3	2	66.7%	13	8	61.5%	0	0	0.0%	0	1	4.0	+15	4	18	84.6%
1/6	MIA	W 122-94	30	12	5	2	1	0	0	9	4	44.4%	0	0	0.0%	9	4	44.4%	0	0	0.0%	1	4	0.0	+18	2	15	66.7%
1/4	WAS	W 141-115	22	5	4	3	0	3	1	9	1	11.1%	1	1	100.0%	10	2	20.0%	0	0	0.0%	1	3	3.0	+28	0	6	25.0%
1/3	MIA	W 125-115	30	11	8	4	1	2	2	8	1	12.5%	5	4	80.0%	13	5	38.5%	0	0	0.0%	2	6	2.0	+24	5	11	42.3%
12/31	ATL	L 126-102	25	6	2	7	0	1	1	6	2	33.3%	2	0	0.0%	8	2	25.0%	0	0	0.0%	2	0	7.0	-10	2	8	37.5%
12/29	CHI	W 136-101	26	12	6	3	0	0	0	9	4	44.4%	1	0	0.0%	10	4	40.0%	0	0	0.0%	0	6	0.0	+28	2	13	60.0%
12/27	BKN	L 123-107	31	11	5	6	0	2	1	6	3	50.0%	1	1	100.0%	7	4	57.1%	0	0	0.0%	0	5	6.0	-22	3	17	78.6%
12/25	DEN	L 142-138	34	6	8	8	1	2	0	7	0	0.0%	4	2	50.0%	11	2	18.2%	2	2	100.0%	2	6	0.0	+12	6	11	25.3%
12/23	NYK	W 115-104	32	11	2	8	0	2	1	7	3	42.9%	2	0	0.0%	9	3	33.3%	4	2	50.0%	0	2	8.0	-11	2	17	51.1%
12/21	MIL	W 103-100	33	18	5	4	0	2	3	8	4	50.0%	3	3	100.0%	11	7	63.6%	0	0	0.0%	0	5	1.3	+0	2	20	81.8%
12/19	OKC	W 112-107	33	15	4	1	0	0	1	10	4	40.0%	2	1	50.0%	12	5	41.7%	3	1	33.3%	2	2	1.0	+12	3	9	56.3%
12/17	MEM	L 116-110	37	19	11	4	1	3	1	11	4	36.4%	5	2	40.0%	16	6	37.5%	6	3	50.0%	4	7	4.0	-8	3	23	51.0%
12/14	SAC	W 117-103	33	18	6	6	2	4	1	9	3	33.3%	9	4	44.4%	18	7	38.9%	2	1	50.0%	3	3	6.0	+15	3	20	47.7%
12/12	GSW	W 127-120	35	21	6	4	1	0	0	10	4	40.0%	5	3	60.0%	15	7	46.7%	4	3	75.0%	2	4	0.0	+16	4	23	62.6%
12/8	PHX	L 108-105	27	2	4	4	0	1	3	6	0	0.0%	1	1	100.0%	7	1	14.3%	0	0	0.0%	1	3	1.3	-9	3	1	14.3%
12/6	LAC	W 109-106	24	5	4	4	0	1	0	4	1	25.0%	2	1	50.0%	6	2	33.3%	0	0	0.0%	0	4	0.0	-5	1	11	41.7%
12/4	NOP	W 125-116	32	15	4	3	1	0	1	8	4	50.0%	2	1	50.0%	10	5	50.0%	1	1	100.0%	1	3	3.0	+6	4	14	71.8%
12/2	NOP	W 149-142	37	15	4	5	1	2	1	15	5	33.3%	1	0	0.0%	16	5	31.3%	0	0	0.0%	1	3	5.0	+6	2	13	46.9%
11/30	SAS	W 125-112	29	18	5	4	0	0	0	9	4	44.4%	5	3	60.0%	14	7	50.0%	0	0	0.0%	2	3	0.0	+13	2	18	64.3%
11/29	BOS	W 119-115	34	15	3	8	0	1	1	7	4	57.1%	2	1	50.0%	9	5	55.6%	2	1	50.0%	0	3	8.0	+10	2	20	75.9%
11/26	OKC	L 113-105	31	11	5	2	0	1	2	6	2	33.3%	3	2	66.7%	9	4	44.4%	2	1	50.0%	1	4	1.0	+6	2	11	55.7%
11/24	SAC	L 117-112	37	17	4	1	0	1	1	13	5	38.5%	1	0	0.0%	14	5	35.7%	2	2	100.0%	0	4	1.0	+6	2	13	57.1%
11/21	PHX	L 114-113	31	9	2	3	0	4	2	7	2	28.6%	2	0	0.0%	9	2	22.2%	3	3	100.0%	0	2	1.5	+9	2	10	43.6%
11/19	WAS	W 120-109	36	12	5	6	0	1	2	6	4	66.7%	2	0	0.0%	8	4	50.0%	0	0	0.0%	0	5	3.0	+10	3	15	75.0%
11/17	DAL	W 120-96	26	14	5	2	2	0	1	7	3	42.9%	1	1	100.0%	8	4	50.0%	4	3	75.0%	1	4	2.0	+35	1	19	71.7%
11/15	DEN	L 123-112	34	11	5	1	0	0	2	6	1	16.7%	5	3	60.0%	11	4	36.4%	2	2	100.0%	1	4	0.5	-23	3	6	46.3%
11/14	SAC	W 124-110	30	20	6	5	0	1	2	10	5	50.0%	1	1	100.0%	11	6	54.5%	4	3	75.0%	1	5	2.5	+17	1	26	78.4%
11/10	UTA	W 120-113	37	14	1	2	1	1	1	8	1	12.5%	3	3	100.0%	11	4	36.4%	5	5	100.0%	0	1	2.0	+18	2	12	53.0%
11/9	SAC	W 144-117	28	8	4	4	1	2	0	6	1	16.7%	1	1	100.0%	7	2	28.6%	3	3	100.0%	3	1	0.0	+15	3	12	48.1%
11/7	UTA	W 137-97	20	3	6	2	1	1	1	4	1	25.0%	0	0	0.0%	4	1	25.0%	0	0	0.0%	1	5	2.0	+20	2	7	37.5%
11/5	NYK	L 137-114	36	21	3	4	0	1	2	11	5	45.5%	4	2	50.0%	15	7	46.7%	2	2	100.0%	1	2	2.0	-14	1	21	66.1%
11/3	BKN	W 125-109	30	25	9	5	1	0	0	13	6	46.2%	4	2	50.0%	17	8	47.1%	4	3	75.0%	3	6	0.0	+12	4	30	66.6%
11/1	CHA	W 122-105	31	18	3	4	0	1	0	12	5	41.7%	2	1	50.0%	14	6	42.9%	2	1	50.0%	0	3	0.0	+12	2	16	60.5%
10/29	LAL	L 116-115	33	14	4	6	0	1	3	5	3	60.0%	2	1	50.0%	7	4	57.1%	3	3	100.0%	1	3	2.0	+7	5	18	84.1%
10/27	DEN	L 127-114	29	12	3	4	0	1	1	8	3	37.5%	2	0	0.0%	10	3	30.0%	3	3	100.0%	0	3	4.0	-7	2	13	53.0%
10/26	IND	W 114-110	37	17	2	3	0	1	1	8	3	37.5%	5	2	40.0%	13	5	38.5%	5	4	80.0%	1	1	3.0	+6	3	14	55.9%
10/24	LAL	L 128-110	28	13	0	4	0	2	0	7	3	42.9%	1	1	100.0%	8	4	50.0%	3	2	66.7%	0	0	0.0	-6	2	14	69.7%
10/22	POR	W 118-114	20	7	4	2	2	2	6	3	1	33.3%	3	2	66.7%	6	3	50.0%	0	0	0.0%	0	4	0.3	-4	1	7	58.3%
Regular Season Totals			30.7	12.3	4.1	3.8	0.4	1.3	1.5	7.9	3.0	38.0%	2.4	1.2	49.7%	10.2	4.2	40.7%	1.3	1.0	74.3%	0.8	3.3	2.6	+336	2.4	15.6	56.9%

Postseason
Date	Opp	Result	MIN	PTS	REB	AST	BLK	STL	TO	3PA	3PM	3P%	2PA	2PM	2P%	FGA	FGM	FG%	FTA	FTM	FT%	OREB	DREB	A/TO	+/-	PF	PER	TS%
4/25	DEN	W 112-96	1	0	0	1	0	0	0	1	0	0.0%	0	0	0.0%	1	0	0.0%	0	0	0.0%	0	0	0.0	+5	0	0	0.0%
4/23	DEN	W 113-96	32	15	4	7	0	4	1	8	3	37.5%	5	3	60.0%	13	6	46.2%	0	0	0.0%	0	4	7.0	+20	4	18	57.7%
4/20	DEN	W 119-114	30	16	7	6	0	1	2	7	4	57.1%	2	2	100.0%	9	6	66.7%	2	0	0.0%	0	7	3.0	+20	3	21	81.0%
4/18	DEN	L 116-105	31	12	4	2	0	2	1	7	4	57.1%	2	0	0.0%	9	4	44.4%	0	0	0.0%	0	4	2.0	+0	3	13	66.7%
Postseason Totals			24.0	10.8	3.8	4.0	0.0	1.8	1.0	5.8	2.8	47.8%	2.3	1.3	55.6%	8.0	4.0	50.0%	0.5	0.0	0.0%	0.0	3.8	4.0	+45	2.5	15.8	65.4%

Donte DiVincenzo: Breaking News

DiVincenzo will undergo surgery Sunday to repair a ruptured right Achilles tendon that he suffered during the Timberwolves' Game 4 win over the Nuggets on Saturday. DiVincenzo will have his surgery done by Dr. Martin O'Malley, the same surgeon who repaired the torn right Achilles of Jayson Tatum in May 2025. The fact that the procedure is taking place within 24 hours of DiVincenzo's injury should help with the recovery, though it would be unfair to expect the veteran guard to return as quickly as Tatum did, which was in essentially 10 months. It seems more likely that DiVincenzo will miss the entire 2026-27 season, though if he does progress enough to return, it wouldn't be until late in the regular season. The Timberwolves will also be without Anthony Edwards (knee) for multiple weeks, so the team will turn to Ayo Dosunmu, Mike Conley and Bones Hyland to carry more of the load for the rest of the postseason.

DiVincenzo has been diagnosed with a torn right Achilles tendon, and he will miss the remainder of the postseason, Shams Charania of ESPN reports. An Achilles tear comes with a lengthy rehab period, so it wouldn't be shocking to see DiVincenzo wind up missing the entire 2026-27 season, but we'll have a better idea of his potential timetable after he undergoes surgery. Ayo Dosunmu and Bones Hyland will help absorb DiVincenzo's minutes in Minnesota.

DiVincenzo (leg) won't return to Saturday's Game 4 matchup with the Nuggets. DiVincenzo suffered a non-contact lower right leg injury, and his diagnosis should become clearer after further testing. His absence will open up minutes for Ayo Dosunmu and Bones Hyland.